Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Lyotropic Therapeutics and Elan establish alliance for development of unique drug delivery system

Nov. 29, 2000

RTI and NIDA identify first potent, selective NET ligand from 3-phenyltropane series

Nov. 27, 2000

Milestone reached in Aventis/PPD Discovery new drug development alliance

Nov. 27, 2000

Interleukin Genetics and Brigham & Women's Hospital investigate genetic control of inflammation

Nov. 15, 2000

Novartis extends R&D collaboration with Cubist

Nov. 14, 2000

Lead compound designated in Structural Bioinformatics/Yamanouchi collaboration

Nov. 14, 2000

Cambridge Drug Discovery signs drug screening agreements with Avidex and RiboTargets

Nov. 13, 2000

Gene discovery collaboration announced by Rosetta and Gemini

Nov. 10, 2000

Human antibody agreement signed by Medarex and Lilly

Nov. 9, 2000

CuraGen reports progress in Biogen research collaboration; Gemini Genomics alliance begins

Nov. 3, 2000

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...